Worldwide revenue of ACS Dobfar 2016-2023

Published by
Juliette Gagliardi,
May 5, 2025

Between 2016 and 2023, the worldwide revenue of Italian chemical-pharmaceutical company ACS Dobfar increased overall. In 2023, in particular, the revenue generated by the company amounted to roughly 669.17 million euros, a record high in the given period. 
ACS Dobfar is a fully integrated provider of pharmaceutical intermediates, active pharmaceutical ingredients and finished dosage forms (oral and injectables).

Revenue of chemical-pharmaceutical company ACS Dobfar from 2016 to 2023 (in million euros)

Loading statistic...

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

May 2025

Region

Worldwide, Italy

Survey time period

2016 to 2023

Supplementary notes

Date of release is date of access

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

8

About the region

10

Selected statistics

10

Other regions

9

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Active pharmaceutical ingredients (APIs) and excipientsGlobal pharmaceutical industryOutsourcing in the pharmaceutical industryBiotech drugsDrug shortages
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.